Elimination Rate Constant

The inverse-time first-order pharmacokinetic coefficient specifying the instantaneous fraction of drug amount eliminated per unit time within a declared compartmental regime.

Version

v3 · 2026-09-06 · History

Domain-specific #

1753

Origin domain

medicine

Subdomain

pharmacokinetics

Aliases

Elimination rate coefficient, Elimination constant, Ke, K E, Terminal elimination rate constant

Core Idea

The elimination rate constant (k_e) is a first-order pharmacokinetic coefficient with units of inverse time. In a one-compartment model after input stops, drug amount (A) follows

\[ \frac{dA}{dt}=-k_eA,\qquad A(t)=A_0e^{-k_et}. \]

It therefore states the instantaneous fraction of the current amount removed per unit time, not a fixed amount removed per hour.^[1]

Under the applicable model, \(t_{1/2}=\ln(2)/k_e\) and (k_e=CL/V), relating the inverse-time coefficient to clearance (CL) and apparent distribution volume (V). These identities depend on the model and must not be applied indiscriminately to multicompartment or nonlinear kinetics.^[2]

The recognition invariant is declared pharmacokinetic compartment/regime + exponential terminal decline + inverse-time coefficient + fraction-proportional elimination.

Structural Signature

• A drug or measured analyte in a pharmacokinetic system.
• Amount or concentration referenced to a declared compartment.
• First-order elimination over the modeled interval.
• A coefficient with time(^{-1}) units.
• Exponential decline after input is absent or accounted for.
• Constant fractional, not constant absolute, removal rate.
• Relation to half-life through \(\ln 2\).
• Relation to clearance and apparent volume under stated assumptions.
• Estimation from an appropriate log-linear slope or model fit.
• Separation of absorption, distribution, and terminal phases.
• Uncertainty, sampling schedule, and assay limits.
• Possible distinction among microconstants and terminal \(\lambda_z\).

What It Is Not

The elimination rate constant is not clearance. Clearance has volume/time units and describes elimination capacity relative to concentration; (k_e) has inverse-time units and depends on the modeled distribution volume. It is not half-life, though the two are reciprocally related in first-order kinetics.

It is not generally constant under saturable, time-varying, nonlinear, or mixed-order elimination, and the terminal slope after an extravascular dose may reflect absorption rather than elimination in flip-flop kinetics.

Scope of Application

The parameter is used in compartmental pharmacokinetics, bioequivalence, exposure prediction, accumulation calculations, washout planning, toxicokinetics, and clinical-pharmacology reporting. Regulators commonly distinguish terminal rate constant \(\lambda_z\) and terminal half-life when analyzing concentration–time data.^[3]

Actual dosing decisions require the complete drug, patient, route, and clinical context; this abstraction supplies a model coordinate, not treatment advice.

Clarity

State whether the value is (k_e), a compartmental microconstant, or noncompartmental terminal \(\lambda_z\); name the matrix, analyte, route, model, fitting interval, units, and uncertainty. Show whether ongoing input, absorption, distribution, or active metabolites affect the observed slope.

Manages Complexity

One coefficient summarizes proportional loss and makes exponential trajectories, half-life, accumulation, and washout calculable. Its strict unit and model requirements prevent dimensional confusion with clearance and force analysts to expose when a convenient one-compartment interpretation is unsupported.

Abstract Reasoning

1. Define the analyte, compartment, and observation matrix.
2. Determine whether first-order elimination is plausible over the interval.
3. Separate input, absorption, and distribution phases.
4. Fit the relevant exponential or full compartmental model.
5. Report (k_e) or \(\lambda_z\) with units and uncertainty.
6. Check residuals and sensitivity to terminal points.
7. Derive half-life only within the same kinetic regime.
8. Relate to clearance and volume only under a compatible model.
9. Reassess under dose, organ-function, or time dependence.

Knowledge Transfer

The portable pattern is encode proportional depletion as an inverse-time constant whose meaning depends on the state variable and model boundary. It transfers to radioactive decay, chemical reaction kinetics, reliability hazards, and population loss models. The proposed immediate parent is Kinetics.

Examples

One-compartment IV bolus. A straight terminal line on a semilog concentration plot has slope \(-k_e\) when distribution is effectively instantaneous relative to sampling.^[1]

Clearance relation. If (CL=6) L/h and (V=30) L in the model, (k_e=0.2) h(^{-1}).

Terminal estimation. Noncompartmental analysis estimates \(\lambda_z\) from selected terminal log concentrations; selection and quantification limits materially affect the result.^[4]

Structural Tensions

• Compact parameter versus model dependence.
• Terminal slope versus true elimination mechanism.
• Sparse sampling versus reliable phase identification.
• Constant fraction versus nonlinear capacity limits.
• Population average versus individual variability.
• Convenient half-life conversion versus multicompartment reality.

Structural–Framed Character

Proportional decay, rate laws, parameter estimation, dimensional analysis, and regime validity are structural. Drugs, compartments, plasma concentrations, clearance, distribution volume, and sampling supply the pharmacokinetic frame.

Structural Core vs. Domain Accent

The portable core is an exponential depletion coefficient. The domain accent is the inverse-time parameter governing drug elimination in a specified pharmacokinetic model.

Instantiates / Related Primes

Kinetics is the proposed immediate parent. Half-Life, Clearance, Volume of Distribution, Exponential Decay, Differential Equation, and Parameter Estimation are related. The parameter is neither covered by the accepted Clearance abstraction nor reducible to a half-life label.

The prospective queue contains one strict edge to domain_specific:kinetics. No live DAG mutation is authorized.

Relationships to Other Abstractions

Current abstraction Elimination Rate Constant Domain-specific

Parents (1) — more general patterns this builds on

• Elimination Rate Constant is a kind of Kinetics Domain-specific

  Kinetics is the proposed immediate parent.

Hierarchy paths (7) — routes to 7 parentless roots

• Elimination Rate Constant → Kinetics → Temporal Dynamics → Time

Show alternative paths (6)

Neighborhood in Abstraction Space

Elimination Rate Constant sits in a sparse region of the domain-specific corpus (95^th percentile for distinctiveness): few abstractions share its structure, so a faithful description tends to retrieve it precisely.

Family — Unclustered & Miscellaneous (1565 abstractions)

Nearest neighbors

• Volume of Distribution — 0.82
• Clearance — 0.81
• Pharmacological Interaction — 0.76
• International unit — 0.75
• Affinity electrophoresis — 0.75

Computed from structural-signature embeddings · 2026-09-08

Not to Be Confused With

• Clearance.
• Elimination rate as amount/time.
• Half-life.
• Absorption rate constant.
• Terminal \(\lambda_z\) without qualification.
• Zero-order elimination.
• A model-free patient constant.

References

[1] Malcolm Rowland and Thomas N. Tozer, Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications, 4^th ed. (Lippincott Williams & Wilkins, 2011). registry ↩a ↩b

[2] Milo Gibaldi and Donald Perrier, Pharmacokinetics, 2^nd ed. (Marcel Dekker, 1982). registry ↩

[3] U.S. Food and Drug Administration, Clinical Pharmacology Section of Labeling for Human Prescription Drug and Biological Products—Content and Format, Guidance for Industry (2016). registry ↩

[4] Johan Gabrielsson and Daniel Weiner, Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications, 5^th ed. (Swedish Pharmaceutical Press, 2016). registry ↩